Clinical Trials Logo

Clinical Trial Summary

In this study, the investigators will investigate the relationship between the blood level of SuPAR at admission to the emergency department of the Clermont-Ferrand University Hospital, and the outcome of patients after their hospitalization in a short stay unit.


Clinical Trial Description

SuPAR (Soluble urokinase Plasminogen Activator Receptor) is a non-specific prognostic blood biomarker related to inflammation. An elevated SuPAR value reflects significant chronic inflammation and predicts a risk of negative outcome and even short-term mortality (intra-hospital, 30 days, 90 days). Conversely, a low SuPAR value is a strong indicator of good prognosis and low risk of readmission. It is therefore of interest to know a patient's SuPAR blood level to enable the clinician to decide whether the patient should be admitted or discharged. SuPAR has been shown to be the best prognostic marker associated with the presence and progression of disease and risk of mortality. The use of SuPAR in clinical routine adds significant complementary information to the standard Early Warning Score assessment and to the classical parameters such as CRP, PCT, Lactate, ALT, Bilirubin, and CBC in the pre-admission of acute patients. Patients admitted to the emergency department will receive their usual management. We will test the added value of the SuPAR assay in the prognosis of patients' outcome at discharge. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05214534
Study type Observational
Source University Hospital, Clermont-Ferrand
Contact
Status Completed
Phase
Start date January 10, 2022
Completion date April 18, 2022

See also
  Status Clinical Trial Phase
Completed NCT05552989 - Towards Better Preparedness for Future Catastrophes - Local Lessons-learned From COVID-19
Not yet recruiting NCT04915690 - Investigation on the Practice Status of Emergency Stuff
Not yet recruiting NCT03424096 - Primary Palliative Care Education, Training, and Technical Support for Emergency Medicine N/A
Completed NCT02534324 - The Effect of Pre-discharge Blood Pressure of Patients With Asymptomatic Severe Hypertension in Emergency Department N/A
Completed NCT00991471 - The Effect of an Physician-Nurse Supplementary Triage Assistance Team on Emergency Department Patient Wait Times N/A
Recruiting NCT03257319 - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department Phase 3
Recruiting NCT05005117 - Laparoscopic Approach for Emergency Colon Resection N/A
Recruiting NCT03917368 - Ultrasound Evaluation of the Jugular Venous Pulse (US-JVP) N/A
Completed NCT04601922 - Qualitative Study of Long Term Cardiovascular Risk Prediction in the Emergency Department
Recruiting NCT05497830 - Machine Learning for Risk Stratification in the Emergency Department (MARS-ED) N/A
Active, not recruiting NCT06220916 - The Greek Acute Dance Injuries Registry
Recruiting NCT05543772 - Evaluation of Blood Sampling From a Pre-existed Peripheral Intravenous Catheter Line Phase 4
Recruiting NCT06072534 - Evaluation of Effectiveness of Two Different Doses of Mivacurium in Rapid Sequence Intubation N/A
Not yet recruiting NCT05528211 - Safety and Efficacy of Emergent TAVI in Patients With Severe AS
Completed NCT05818215 - Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
Recruiting NCT04615065 - Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine
Active, not recruiting NCT05221697 - Effect of an ML Electronic Alert Management System to Reduce the Use of ED Visits and Hospitalizations N/A
Active, not recruiting NCT04648449 - Artificial Intelligence (AI) Support in Medical Emergency Calls
Not yet recruiting NCT04431986 - ER2 Frailty Levels and Incident Adverse Health Events in Older Community Dwellers
Completed NCT05597059 - The Diagnostic Value of the First Clinical Impression of Patients Presenting to the Emergency Department (PREKEYDIA)